 |
 |
|
Rare Disease Therapeutics, Inc* is an established biopharmaceutical company focused on development, registration, and distribution of orphan products in the United States as well as globally through a consortium of similarly focused companies.
 |
|
What's
New? Rare Disease Therapeutics, Inc. is currently developing orphan products, acquiring orphan products through strategic alliances, and distributing orphan products throughout the Americas. The company works closely with the FDA Office of Orphan Product Development, National Organization of Rare Disorders, patient advocacy groups, and the National Institutes of Health to identify the unmet needs of patients with rare disorders and potential products to meet these needs.
WE'RE MOVING! Please note that our new address will be effective as of June 27, 2008:
|